About
GRO™
Focus Areas
Team
Portfolio
News
Login
Contact

Category: Uncategorized

October 27, 2025

Wilmington PharmaTech Appoints Industry Veteran Kent Payne as Managing Director and Board Member

October 21, 2025

Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital

August 20, 2025

Curewell Capital Closes Oversubscribed Inaugural Fund at $535 Million

December 15, 2023

AMR Continues Expansion with Acquisition of Affinity Health

September 1, 2023

AMR Appoints Kari L. Delahunty Chief Operating Officer

April 18, 2023

WeInfuse Establishes Infusion Technology Advisory Council

March 2, 2023

WeInfuse Secures Growth Capital Infusion from Curewell Capital

March 21, 2022

Curewell Capital Acquires the Alliance for Multispecialty Research (“AMR”) in Partnership with Management

© 2025 Curewell Capital. All rights reserved. Design by SPINX Digital

Disclosures
Terms of Use
Privacy Policy